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Abstract 
A comprehensive continuum model of solid tumor evolution and development is 
investigated in detail numerically, both under the assumption of spherical symmetry and 
for arbitrary two-dimensional growth. To our knowledge, this is the first investigation of 
the multicell model developed by De Angelis and Preziosi (2000) as a moving boundary 
problem in higher dimensions and arbitrary geometries. The model represents both the 
avascular and the vascular phase of tumor evolution, and is able to simulate when the 
transition occurs; progressive formation of a necrotic core and a rim structure in the 
tumor during the avascular phase are also captured. In terms of transport processes, the 
interaction of the tumor with the surrounding tissue is realistically incorporated. A 
computational framework, based on a Cartesian mesh/narrow band level-set method, has 
been developed in order to solve the coupled advection-diffusion model equations with a 
moving boundary inside a fixed domain. The solution algorithm is designed so that 
extension to three-dimensional simulations is straightforward.  
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  11. Introduction 
 
Over the last ten years, a number of important advancements have been made in the 
development of mathematical models to simulate the growth and macroscopic behavior 
of solid malignant tumors. The recent reviews by Araujo and McElwain [5] and Bellomo, 
et al. [6] contain extensive bibliographies and categorize the different solid tumor growth 
models. As in many areas of fundamental and applied science, the increasing 
sophistication of computational models make them an important part of the study of 
complex multi-scale phenomena. Verifiable computational models will likely become 
part of the arsenal of techniques used to better understand tumor evolution and treatment 
strategies in the near future. Continuum-based models can be used to help predict the 
evolution of a tumor's boundary in time and this knowledge may in turn help estimate the 
effect that various methods of treatment (e.g., chemotherapy, ultrasound) may have on 
the tumor behavior as well as on the surrounding healthy tissue and, ultimately, on the 
host.   
Malignant solid tumors are masses of tissue formed as a result of abnormal and 
excessive proliferation of mutant (atypical) cells, whose division has escaped the 
mechanisms that control normal cellular proliferation. This abnormal proliferation of 
atypical cells can lead to uncontrolled growth, if not checked by the immune system. In 
simple terms, tumor growth (spread of malignant cells) can be described as follows: when 
fed with a sufficient amount of nutrient, malignant cells divide (cellular mitosis); when 
the density of cells in a specific volume becomes high, the cells are compressed by their 
neighbors and tend to move to less populated areas–where they may continue to 
  2proliferate–and this process is repeated. The growing tumor mass eventually begins to 
interact with the surrounding tissue and may eventually evolve in a complex manner. 
    There are different stages of a malignant tumor evolution; described roughly, the main 
stages are the cellular stage and the macroscopic stage. The cellular stage refers to the 
early stage of a tumor evolution, when proliferating tumor cells have not begun to 
agglomerate. The macroscopic stage comes about when clusters of atypical cells 
condense together into a compact shape (e.g., spherical); this stage is sub-divided into 
two subsequent phases−the avascular phase and the vascular phase. During the avascular 
phase, the tumor obtains nutrients via diffusion processes alone from the local 
environment.  In the second phase, called the vascular phase, the tumor attempts to 
develop its own blood supply through the process of angiogenesis (i.e., the birth of new 
blood vessels). Malignant tumor cells secrete chemicals that diffuse outward into the 
surrounding healthy tissue and stimulate the growth of new capillary blood vessels; the 
newly formed blood vessels penetrate into the tumor mass feeding it with nutrients and 
leading to a rapid growth of the tumor (Folkman, [16]).   
    Due to the extremely complex nature of the biological systems underlying the behavior 
in tumors and to the limited understanding of tumor growth mechanisms, developing 
realistic models (mathematical, computational or both) is a difficult task. Currently, there 
are two major approaches for solid tumor growth modeling: the first employs continuum 
models to describe the evolution of the tumor in terms of systems of partial differential 
equations and/or non-linear integro-differential equations; the second approach uses 
discrete lattice or Cellular Automata (CA) models (e.g., Kansal, et al., [19]; Mansury and 
Diesboeck, [24]). For the macroscopic stage of tumor evolution, the continuum approach 
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estimated, the advantage of a continuum model is that it provides a systematic means for 
evaluating the role played by individual physical mechanisms. However, the more 
complex the continuum model−the more difficult the computational simulations, since a 
continuum model will generally yield a nonlinear moving boundary problem described 
by systems of partial differential equations. The starting point for many continuum 
models is the pioneering work of Greenspan in the 1970's (see Araujo and McElwain, [5] 
and references therein). In recent years a variety of macroscopic continuum models have 
been derived employing analogies with inorganic systems (theory of mixtures, 
multiphase flow, e.g., Byrne, et al. [8] or Byrne and Preziosi [9]). While currently quite a 
few such complex models exist in the literature, computational simulations in arbitrary 
geometries and higher dimensions to further investigate and validate these models are 
still largely missing. Only very recently, such calculations have started to emerge 
[14],[40]. 
          The goal of the present work is to investigate a recent comprehensive model 
DeAngelis and Preziosi (2000) [15], which involves multiple cell populations as well as 
chemical species. From a mathematical/computational point of view, the model is 
complex since it consists of a system of five PDEs, with some of the field variables as 
well as some of the coefficients discontinuous across the tumor boundary; the tumor 
surface evolves in time, and its location must be determined as part of the solution. At the 
same time, from a biological point of view, this model is very appealing for the following 
reasons: first of all, it captures both the avascular and the vascular stages of tumor growth 
(based on nutrient levels, the model predicts evolution from the avascular phase into the 
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environment (primarily in terms of the angiogenesis phenomenon); third, effects of 
potential treatments on the tumor evolution can be readily investigated by varying the 
model parameters. 
    A  general  computational  framework  for obtaining multi-dimensional solutions to 
continuum-based models for numerically simulating tumor growth has been developed 
and is described in Hogea, et al. [17]. In that work, the solution methodology is tested on 
a simplified, two-equation model. Finite-differences on a fixed Cartesian grid are 
employed to discretize the field equations, and the level set method is used to determine 
the location of the evolving tumor boundary. Here, the methodology is applied to the 
complex model involving coupled nonlinear reaction/advection/diffusion equations [15] 
in a two-region domain with an evolving tumor boundary. 
    The structure of the paper is as follows: Section 2 reviews the mathematical tumor 
growth model developed in DeAngelis and Preziosi [15]; Section 3 provides a brief 
description of the general formulation of the level set method; Section 4 investigates the 
spherically symmetric case –both from a biological and a computational point of view; a 
comparison of the tumor evolution in time simulated via two different numerical methods 
(a pseudo-Lagrangian and a level set – Eulerian one respectively) is performed; Section 5 
presents the numerical algorithms for higher dimensions and arbitrary geometries; 
Section 6 contains two-dimensional simulations of tumor evolution in arbitrary 
geometries and various case scenarios for the model considered here; finally, Section 7 
contains some remarks regarding further research. 
 
  52.  Tumor growth model description 
 
 De Angelis and Preziosi [15] present a detailed derivation of the mathematical model  
under investigation here. The model is summarized below. A slightly modified version is 
reconsidered in Chaplain and Preziosi [11]. Geometrically, there are two regions in the 
model: the inner region occupied by the tumor mass is time-dependent and denoted by 
; the tumor region is embedded in a larger fixed domain denoted by D. The region 
 is referred to as the (tumor) outer environment.  
) (t Ω
) ( ) ( t D t
out Ω − = Ω
There are two classes of model dependent variables characterizing the physical state 
of the biological system (i.e., in both the tumor mass and the outer environment): cell 
populations and chemical species (macro-molecules). They are essentially different: the 
cell size is much larger than that of the macro-molecules; the cells are delimited by a 
membrane and can not penetrate each other; they occupy actual physical space. By 
contrast, the chemical species consist of macro-molecules that may diffuse in the 
intercellular space, attach to the cell membrane or penetrate it, such that they actually do 
not take up physical space.  
The following cell populations and chemical species are defined: 
 
•  living tumor cells – represented by the density  ) , ( t x u u T T
r
=   
•  dead tumor cells – represented by the density  ) , ( t x u u D D
r
=  
•  new capillaries (i.e., endothelial cells) with density  ) , ( t x u u C C
r
=  
•  nutrient concentration  ) , ( t x u u N N
r
=   
•  tumor angiogenic factor (TAF) concentration   ) , ( t x u u A A
r
=  
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In a continuum mechanics framework, a standard mass balance law leads to a general 
reaction-advection-diffusion equation for each of the model variables introduced above: 
) ( ) ( ) ( ) ( u L u u W u Q
t
u
− Γ + • ∇ − ∇ • ∇ =
∂
∂ r
               (2.1)  
where: 
 
•   is the generation (proliferation/production) term;  ) (u Γ = Γ
•   is the death/decay term;  ) (u L L =
•  is the drift velocity field;  W
r
•   is the diffusion coefficient.   Q
 
The following  modeling assumptions are made (from a biological viewpoint) in order to 
specify the exact form of Eq.(2.1) for each of the continuum model field variables: 
 
I.  Regarding the tumor cells (living and dead) 
1.  living tumor cells proliferate (cellular mitosis) only if the levels of nutrient reaching 
       them are sufficient (i.e., above a certain threshold denoted by  N u ~ ); 
2.  living tumor cells die if the levels of nutrient reaching them are too low (i.e., below 
       the threshold denoted by  N u ); 
3.  once a number of living  cells inside the tumor have died due to insufficient 
nutrient, the nutrient  becomes sufficient for the remaining ones to survive; thus, 
there is a smooth transition to a necrotic region; 
  74.  when crowded by their neighbors, the living tumor cells have the ability to migrate 
      towards lower density areas where they have higher chances of surviving and 
      proliferating; 
   5.  dead tumor cells do not move; 
   6.  dead tumor cells are assumed to naturally disintegrate into waste products (water). 
 
II. Regarding the tumor angiogenic factor (TAF) 
1.  living tumor cells are constantly producing TAF from a point on (in the revised 
      version, the  assumption is made that living tumor cells  produce TAF only when 
      they lack nutrient – i.e., haptotaxis occurs); 
2.  TAF diffuses both inside the tumor region and outside in the surrounding 
      environment; 
3.  TAF naturally degrades 
 
III. Regarding the new capillaries 
1.  endothelial cells reached by TAF are stimulated to proliferate (cellular mitosis) at a 
rate proportional to the concentration of TAF; proliferation decreases with the 
density of new capillaries; in particular, proliferation stops if the density of the new 
capillaries becomes higher than a certain threshold – here denoted by  C u ; the 
endothelial cells first stimulated are those belonging to the pre-existing capillary 
network, ) ( ˆ ˆ x u u C C
r
= , in the tumor outer environment (the spatial distribution is 
prescribed initially in the model and is  assumed time-independent); 
  82.  new endothelial cells undergo both a random motion (diffusion) and an ordered one 
(chemotaxis) oriented towards the source of angiogenic stimulus (TAF) with 
formation of new capillary sprouts by accumulation of endothelial cells; 
3.  newly formed endothelial cells undergo apoptosis. 
 
IV. Regarding the nutrient: 
1.  the nutrient in the tumor outer environment is provided by the capillary network at a 
linear rate; in particular, in the absence of new capillaries, the amount of nutrient in 
the tumor outer environment is constant; 
2.  diffusion of nutrient inside the tumor is promoted by the presence of capillaries, 
with the diffusion coefficient assumed to increase linearly with the density of 
capillaries; 
3.  nutrient is consumed by the living tumor cells. 
 
The model assumes that all cells (living cells, dead cells and endothelial cells) equally 
contribute the overall cell density defined as: 
                 ( 2 . 2 )   C C D T u u u u u ˆ + + + =
It is assumed that there is a threshold overall cell density – here denoted by u and called 
the close packing density (by analogy with multiphase flow terminology) – characterizing 
the fact that no pressure is felt by a cell when the total density u  is equal to it (i.e. the 
stress vanishes for  u u = ). 
    All the above modeling assumptions are placed in the context of the general advection-
diffusion equation (2.1) for each of the field variables (densities or concentrations). For 
  9simplicity, assume that the diffusion coefficients for TAF and new capillaries are 
constant in   (in particular, this implies that they are continuous across the tumor 
boundary). The drift coefficients for the living tumor cells and endothelial cells are also 
assumed constant and positive. Under these last additional assumptions, the following 
model governing equations are employed here: 
D
 
 
-  in  :      D
⎪
⎪
⎩
⎪ ⎪
⎨
⎧
− + − + ∇ • ∇ − ∇ =
∂
∂
− + ∇ =
∂
∂
+ C C C C C C A C A C C C C
C
A A T A A A
A
u u u u u u u u w u k
t
u
u u u k
t
u
δ γ
δ γ
) ˆ ( ) ( ) (
2
2
     (2.3)  
    and 
-  in  :  ) (t Ω
⎪
⎪
⎪
⎩
⎪
⎪
⎪
⎨
⎧
− ∇ + + • ∇ =
∂
∂
− − =
∂
∂
− − − + ∇ • ∇ =
∂
∂
N T N N C C N E
N
D D T N T N T
D
T N T N T T N N
T N T
T T
T
u u u u u k k
t
u
u u u u u H
t
u
u u u u H u u u H
u u
u u w
t
u
δ
δ δ
δ
ε
γ
] )) ˆ ( [(
) (
) ( ) ~ ( ) (
   (2.4) 
 
In the above equations it is naturally assumed that  0 ) , ( = t x uT
r
 and   if  0 ) , ( = t x uD
r
) (t x
out Ω ∈
r
(in particular, they are discontinuous quantities across the tumor boundary), H  
is the Heaviside function:   and 
⎩
⎨
⎧ >
=
otherwise
u if
u H
, 0
0 , 1
) ( ) 0 , max(f f = +  denotes the 
positive part of the function  .  f
 Production (growth) coefficients are denoted by γ ; death (degradation) coefficients by 
δ ; diffusion coefficients by  ; transport (drift) coefficients by  . In the equation for the  k w
  10nutrient diffusion inside the tumor (last equation (2.4)),   stands for the diffusion 
coefficient in the absence of capillaries, while   measures the dependence of the 
diffusion rate on the presence of capillaries; both of them will be assumed constant here. 
In the evolution equation for the tumor living cells (first equation in 2.4), the parameter ε 
represents the amount of nutrient existent in the environment in the avascular phase. The 
function 
E k
N k
) ( ˆ ˆ x u u C C
r
=  (representing the density of the pre-existing capillaries) is modeled 
as a smooth function with compact support outside the domain occupied initially by the 
tumor. While various mathematical possibilities might exist to construct such a function 
to specifications - depending on the biological and/or computational instances, here the 
simplest case of a “bump function” shall be employed: 
⎩
⎨
⎧
− ∈
= Ω ⊂ ∈ >
=
O D x if
t S x if t cons
x u
out
C r
r
r
, 0
) 0 ( , 0 tan
) ( ˆ             (2.5) 
where  represents the fixed region in space occupied by the pre-existing capillary 
network , with compact closure
S
S  and O is an open set arbitrarily close to S that 
contains S . 
Assuming that the tumor boundary is stress-free, that the nutrient at the tumor surface is 
the nutrient existent in the outer environment and that there are no dead cells at the tumor 
surface in the case of an expanding tumor, the following boundary conditions for the 
model governing equations (2.4) are imposed:  
- on  :  ) (t Ω ∂
⎪
⎩
⎪
⎨
⎧
=
+ + =
− − − =
0
) ˆ (
ˆ
D
C C N
C C D T
u
u u u
u u u u u
β ε                       (2.6) 
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substantially towards the boundaries of the tumor outer environment, the boundary 
conditions for the model governing equations (2.3) can be taken as: 
- on  :                         ( 2 . 7 )   D ∂ 0 = = C A u u
Treating the tumor boundary   as a material interface moving with the tumor cells at 
the tumor surface, its normal velocity is given by: 
) (t Ω ∂
) ( ) ( t t T n u w v Ω ∂ Ω ∂ • ∇ − =
r
                 (2.8) 
where  ) (t n Ω ∂
r
is the local outward unit normal to the tumor boundary  ) (t Ω ∂ .    
Finally, to complete the mathematical model, initial conditions are needed for the model 
governing equations (2.3) and (2.4):  
- in  :            D 0 0 0 = = = = t C t A u u                 ( 2 . 9 )  
- in  0 ) ( = Ω t t : 
⎪
⎩
⎪
⎨
⎧
=
=
=
=
=
=
ε 0
0
0
0
t N
t D
t T
u
u
u u
             ( 2 . 1 0 )  
These initial conditions correspond to a realistic scenario at some point during the tumor 
avascular phase, where a nucleus consisting solely of uncompressed living malignant 
cells finds itself in an environment full of nutrient and starts releasing TAF to induce the 
angiogenesis process. 
    Using  the  same  characteristic  scale  values as De Angelis and Preziosi [15], the 
following dimensionless variables are introduced: 
t t T γ =
*           (dimensionless time) 
x
k
u
x
E
N r r δ
=
*     (dimensionless  space)             
  12C D T j
u
u
U
j
j , , , = =                   ( 2 . 1 1 )  
ε
N
N
u
U =  
A
A
T
A u
u
U
γ
γ
=  
 
By scaling the dimensional equations and boundary/initial conditions, the following two 
non-dimensional, coupled initial/boundary value problems are obtained [15]: 
- in : 
* D
 
         
⎪
⎪
⎩
⎪ ⎪
⎨
⎧
∆ − + − Γ + ∇ • ∇ − ∇ =
∂
∂
∆ − + ∇ =
∂
∂
+ C C C C C C A C A C C C C
C
A A T A A
A
U U U U U U U U W U K
t
U
U U U K
t
U
) ˆ ( ) ( ) (
2
*
2
*
(2.12) 
 
- on  :                   ( 2 . 1 3 )  
* D ∂ 0 = = C A U U
- in  :        
* D 0
0 0
* * = =
= = t C t A U U             ( 2 . 1 4 )  
- in :  ) (
* * t Ω
 
          
⎪
⎪
⎪
⎩
⎪
⎪
⎪
⎨
⎧
− ∇ + + • ∇ ∆ =
∂
∂
∆ − − ∆ =
∂
∂
− ∆ − − + ∇ • ∇ =
∂
∂
} ] )) ˆ ( 1 [( {
) (
) ( )
~
( ) (
*
*
*
N T N C C N N
N
D D T N T N T
D
T N T N T T N N N T T T
T
U U U U U K
t
U
U U U U U H
t
U
U U U U H U U U H U U U U W
t
U
     (2.15) 
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- on  :                ( 2 . 1 6 )   ) (
* * t Ω ∂
⎪
⎪
⎩
⎪ ⎪
⎨
⎧
=
+ Β + =
− − − =
0
) ˆ ( 1
ˆ 1
D
C C N
C C D T
U
U U U
U U U U
 
- in 
0
* *
* ) (
= Ω
t t : 
⎪
⎪
⎩
⎪ ⎪
⎨
⎧
=
=
=
=
=
=
1
0
1
0
0
0
*
*
*
t N
t D
t T
U
U
U
             ( 2 . 1 7 )  
 
 The corresponding scaled normal velocity of the tumor boundary is given by: 
* * Ω ∂ Ω ∂ • ∇ − = n U W V T
r
                         (2.18) 
 
In the scaled equations (2.12)-(2.18), spatial differentiation is with respect to the 
dimensionless spatial coordinate variables, represented in vector form by 
* x
r
, and the 
following dimensionless model parameters (i.e., diffusion coefficients, drift velocities, 
growth/death coefficients and threshold densities) appear: 
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u
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u
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W
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W
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K
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K
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C
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T
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A C
C
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C
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N
N
T E
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A
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,
, ,
2
2
2
2
2
          (2.19) 
 
In order to investigate the model behavior, Eqns. (2.12) and (2.15) with the prescribed 
boundary and initial conditions (2.13)-(2.14) and (2.16)-(2.17), respectively, are solved 
numerically to determine the unknowns  ; the new location of the 
tumor boundary is then found by employing the normal velocity expression given by 
(2.18). In everything that follows, the “star” notation in all the above dimensionless 
model equations (2.12)-(2.18) is dropped for simplicity, and all references to the various 
model parameters (e.g., diffusion coefficients, drift velocities, etc) will be to the 
corresponding dimensionless parameters (2.19). 
N D T C A U U U U U , , , ,
 
3. Level  set  formulation 
 
As previously defined, let  ) (t Ω = Ω  denote the (scaled) domain occupied by the 
tumor,   the (scaled) tumor outer environment, and  ) (t
out out Ω = Ω ) ( ) ( t t Ω ∂ = Σ = Σ  (a 
curve in 2D and a surface in 3D, respectively) be the boundary of the tumor, separating 
  15the tumor and the outside tissue. This boundary evolves in time with a normal velocity 
given by Eq. (2.18), and the problem is finding the location of the tumor boundary at 
later moments in time starting from a known location at the initial moment of time 
. One way to do so is by employing the level set method introduced by 
Osher and Sethian [27] and  based in part on the theory and numerics of curve evolution 
developed by Sethian [32],[33].  The basic idea behind the level set method is to 
introduce an additional variable, denoted by      
V
) 0 ( 0 = Σ = Σ t
           ) , 0 [ , ), , ( ∞ ∈ Ω ∪ Σ ∪ Ω ∈ = t x t x
out r r
ϕ ϕ ,  
responsible for capturing the front  ) (t Σ = Σ  in an implicit fashion at each moment in 
time: 
{} 0 ) , ( ) ( = = Σ = Σ t x x t
r r
ϕ  
The function  ) , ( t x
r
ϕ ϕ = is the level set function. First, the initial level set function value 
is set equal to the signed Euclidean distance function to the tumor boundary at the initial 
moment of time (taken negative inside the tumor and positive outside): 
 
⎪
⎩
⎪
⎨
⎧
= Ω ∈ Σ
Σ ∈
= Ω ∈ Σ −
=
) 0 ( , ) , (
, 0
) 0 ( , ) , (
) 0 , (
0
0
0
t x x dist
x
t x x dist
x
out r r
r
r r
r
ϕ               (3.1) 
 
At any moment in time, the location of the tumor boundary is given by the zero level set 
of the level set function. For a particle on the front with the path  ) (t x x
r r
=  one has: 
0 ) ), ( ( = t t x
r
ϕ   
The kinematics governing the motion of the boundary yields: 
  160 , 0 ) ( ) ), ( ( > ∀ = • ∇ +
∂
∂
= t t
dt
x d
t t x
t dt
d
r
r
ϕ
ϕ ϕ
 
The outward unit normal on the boundary is given in terms of the level set function by: 
           
ϕ
ϕ
∇
∇
= n
r
                  ( 3 . 2 )  
Substituting (3.2) in the above equation leads to the evolution equation for the level set 
function (initial value formulation): 
  0 = ∇ +
∂
∂
ϕ
ϕ
F
t
                 ( 3 . 3 )  
where 0 , ), , ( > Ω ∪ Σ ∪ Ω ∈ = t x t x F F
out r r
 represents what is typically called an 
“extension velocity” field (i.e., defined  everywhere, such that it always matches the 
given expression of the normal velocity V on the tumor boundary Σ): 
  ) ( ) ( ) , ( ) , ( t x t x t x V t x F Σ ∈ Σ ∈ = r r r r
                ( 3 . 4 )  
Eq. (3.3) correctly moves the boundary with the prescribed normal velocity given by 
(2.18).       
As compared to an explicit front-tracking formulation, there are considerable advantages 
of the level set formulation for this problem: 
•  the domain occupied by the tumor at each moment of time and the corresponding 
outer environment are apparent from the sign of the level set function (here taken 
negative the tumor region and positive outside); 
•  the local geometric properties of the tumor boundary (e.g. the normal) are readily 
available; 
•  the same formulation holds regardless of the number of spatial dimensions (1,2 or 
3); 
  17•  enhanced implementations such as “the narrow band method” introduced by 
Adalsteinsson and Sethian [1] or “the fast marching method” [2],[34] are available 
that make the boundary capturing more computationally  efficient. 
 On the other hand, some challenges arise when implementing the level set method: 
•  construction of the “extension velocity” field  in the level set equation (3.3) 
(generally, there is no natural choice for this field which is only defined on the 
interface itself); 
F
•  re-initialization of the level set function ϕ  as a signed distance to the interface. 
  
 
4.  The spherically symmetric case 
 
Solution procedures to the model equations (2.12) and (2.15) with the corresponding 
initial and boundary conditions are developed in this section under the assumption of 
spherical symmetry; both for computational purposes – to test the applicability of a level 
set approach – and for biological ones – to check the model behavior. The tumor is 
regarded as a growing sphere, of radius  , with a given initial radius  . The model 
dependent variables  ,
) (t R 0 R
) , ( t r U U A A = ) , ( t r U U C C = ,U ) , ( t r UT T = ,  and 
, where 
) , ( t r U U D D =
) , ( t r U U N N = r denotes the radial coordinate. The domain occupied by the tumor 
is then  { } ) ( 0 ) ( t R r r t ≤ ≤ = Ω = Ω , embedded into a larger fixed sphere of given radius 
:  D R {} D R r r D ≤ ≤ = 0 . 
  18Each of the governing equations (2.12) and (2.15) can be cast in the general compact 
form: 
) ( ) ( ) ( ) ( µ µ ν µ µ
µ
L W Q
t
− Γ + ∇ • ∇ − ∇ • ∇ =
∂
∂
                                                 (4.1) 
where   is constant and positive in Eqns. (2.12), zero in the first two Eqns. (2.15) 
variable in the last equation (2.15); W  is constant and positive in the second equation 
(2.12), constant and negative in the first equation (2.15) and zero in all the remaining 
equations; 
Q
ν depends explicitly on µ  only in the first equation (2.15). In (4.1), µ  and ν  
represent the various model dependent variables to be determined numerically. Rewriting 
(4.1) in spherical coordinates under the assumption of spherical symmetry 
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For discretization purposes, it is convenient to rewrite (4.2) in non-conservative form: 
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The form (4.3) is preferred here mainly for two reasons: the contribution of lower order 
terms is individually highlighted for each of the model dependent variables – which 
makes a heuristic stability assessment [30] easy to conduct when a fully-explicit finite 
difference scheme is employed to solve numerically the nonlinear equations (4.3); then, 
in an Eulerian formulation, with a fixed grid and a moving boundary captured implicitly 
via a level set method, the spatial finite difference scheme at grid points adjacent to the 
boundary must be modified to take into account the prescribed boundary conditions. The 
latter is accomplished here by separately constructing second order interpolating 
  19polynomials for each of the model dependent variables – or, in the framework of Eq. 
(4.1), for each of the unknowns µ  and ν . It is clearly then why a non-conservative 
version of (4.1), that will highlight the first order derivatives of µ  and ν  separately, is 
employed. However, an alternate ghost fluid method (GFM) formulation [26] allows for a 
conservative form. 
Another aspect of primary importance when proceeding to the spatial discretization of the 
model Eqns. (2.12) – that are valid in the entire fixed computational domain   - is 
deciding whether to discretize them separately inside the region occupied by the tumor 
and outside respectively. This is the approach employed here, for the following reasons: 
in more general cases, the diffusion coefficients of TAF and of the new capillaries might 
be different inside the tumor and in the outer environment respectively; then, the 
production (source) term in the TAF equation is discontinuous across the tumor 
boundary; and finally, splitting the larger problem into two smaller ones – a domain-
decomposition approach – is certainly very valuable in the perspective of a semi-
implicit/implicit time discretization.  
D
All the numerical results presented in this paper are obtained by employing a fully 
explicit (forward Euler) time discretization; alternate time-splitting/linearization schemes 
are currently under investigation by the authors – but the nonlinear diffusion type term 
 in the equation for the living tumor cells (the first 
equation (2.15)) coupled with the need to modify the spatial stencil at fixed grid points 
adjacent to a moving boundary make the problem challenging and computationally   
intensive; moreover, assessing the overall correctness and consistency [30],[38] of such 
schemes is a delicate aspect, particularly when no other results exist for comparison. 
)) ˆ ( ( C C D T T U U U U U + + + ∇ • ∇
  20While the fully explicit method in an Eulerian framework with a moving boundary 
certainly leads to severe constraints on the time step, it naturally handles the fully 
nonlinear problem and the overall computational efficiency might prove equivalent to 
that involved in a less constrictive time-splitting method; the numerical results presented 
here shall show that a fully explicit method can be used as a basic computational tool to 
investigate the model behavior for model parameters in a certain range, particularly when 
no previous simulations have been performed and at least a preliminary assessment of the 
model from a biological point of view is desired. 
 
 
4.1 A pseudo-Lagrangian solution method  
 
For the spherically symmetric case it is possible to employ a coordinate transform 
and fix the location of the tumor boundary in the transformed domain (Landau 
transformation). A solution procedure using this method was developed for comparison 
purposes with the level set approach. For the tumor boundary location defined by R(t), 
the following transformed coordinates are defined: 
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  21At each moment of time , the inside of the tumor is being mapped onto the interval   
the outside of the tumor is being mapped onto the interval   and the tumor boundary 
is located at 
t ] 1 , 0 [,
] 2 , 1 [
1 = =η ξ . Employing the chain rule in (4.3) yields: 
 
1 0 , ) ( ) (
)]
2
(
2
[
) (
1
) (
) (
2
2
2
2
2
< < − Γ +
∂
∂
+
∂
∂
∂
∂
+
∂
∂
−
∂
∂
+
∂
∂
∂
∂
+
∂
∂
+
∂
∂
=
∂
∂
ξ µ µ
ξ
ν
µ
ξ ξ
ν
ξ
µ
ξ
ν
µ
ξ
µ
ξ ξ
µ
ξ ξ
µ
ξ
µ
ξ
µ
L
W Q
Q
Q
t R t R
t R
t
&
 (4.5) 
 
and 
 
2 1 , ) ( ) ( ) (
) (
1
)) ( )( 1 ( ) (
2
)] ( [
)) ( (
1
) (
) (
) 2 ( 2
2
2
2
2
< < − Γ +
∂
∂
−
∂
∂
− − − +
+
∂
∂
∂
∂
+
∂
∂
−
∂
∂
∂
∂
+
∂
∂
−
+
∂
∂
−
− − =
∂
∂
η µ µ
η
ν
µ
η
µ
η
η
ν
η
µ
µ
ν
µ
µ
µ
η η
µ
η
µ
η
µ
L W Q
t R R t R R t R
W
Q
Q
t R R t R R
t R
t
D D
D D
&
(4.6) 
 
where  ) ( ) ( t
dt
dR
t R = & . 
Clearly, the model governing equations (2.15) satisfied inside the domain occupied by the 
tumor only are of the form (4.5), while the model equations (2.12) – valid in the entire 
computational domain – are split into two: inside the domain occupied by the tumor and 
outside respectively, thus they are of the form (4.5) - inside and (4.6) – outside. In this 
case, additional matching conditions at the tumor boundary are needed for the 
corresponding model dependent variables   and   respectively; these will be 
obtained by naturally assuming continuity of   and   and of the related fluxes 
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  22n u k A A
r
• ∇ ) (  and  n u u w u k A C C C C
r
• ∇ − ∇ ) (  across the tumor boundary, which here leads 
to: 
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Symmetry boundary conditions are employed at the tumor center  0 = r : 
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According to Eq. (2.18), the tumor radius   evolution in time is given by:  ) (t R
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Description of the numerical algorithm: 
 
•  The “inner” domain  1 0 ≤ ≤ξ  and the “outer” domain  2 1 ≤ ≤η  are each 
discretized using equally spaced meshes; the interface is a mesh point, 
corresponding both to  1 = ξ  and  1 = η . 
  23•  The interface motion equation (4.9) is discretized using forward differencing in 
time and second order backward differencing in space (since the global cell 
density   is discontinuous across the interface); therefore, 
the new location of the interface at the current time step is obtained by using the 
location of the interface at the previous time step and the global cell density at the 
previous time step. 
C C D T U U U U U ˆ + + + =
•  The “inner” set of model governing equations (4.5) is discretized at all the internal 
mesh points using forward differencing in time and regular second order centered 
differences in space both for the second order and for the first order derivatives; 
similarly for the “outer” set (4.6); thus, the new values of the model state 
variables at the current time step are determined at all internal mesh points – both 
inner and outer. To update the current values of the state variables at the interface 
– which is both an “inner” mesh point and an “outer” mesh point, the matching 
conditions (4.7) are first used to determine the current values of   and   
respectively at the interface; once the value for   is known at the current time 
step, then the model boundary conditions (2.16) are used to update the values of 
 and   at the interface at the current time step. 
A U C U
C U
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The implementation of the above algorithm is straightforward; the numerical stability and 
ultimately the convergence of the explicit method depends on the choice of the model 
parameters. More comments follow in the results section 4.3. 
 
4.2 A level set (Eulerian) solution approach 
 
  24The detailed description of the numerical algorithm for the fixed Cartesian 
mesh/level set approach in two dimensions and arbitrary geometries is addressed in 
Section 5 and Appendix A. The same general formulation holds regardless of the number 
of spatial dimensions (1,2 or 3). Below the formulation is outlined for the spherically 
symmetric case; this is done from a computational perspective for comparison purposes 
and to assess the applicability of the proposed computational methodology for the current 
complex tumor growth model. 
As in section 4.1 above, symmetry conditions are employed at the tumor center  .   0 = r
As previously, continuity of   and   and of the related fluxes across the tumor 
boundary  , which here translates into the continuity of  ,  , 
A u C u
) (t R r = A U C U
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∂
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at  , shall also be employed.  ) (t R r =
 
Description of the numerical algorithm: 
 
•  The entire fixed computational domain  D R r ≤ ≤ 0  is discretized using equally 
spaced meshing; the interface  ) (t R r =  in this case is generally not a mesh point. 
•  The new location of the interface at the current time step is given by the zero level 
set function at the current time step; the level set equation (3.3) in this case reads: 
0 =
∂
∂
+
∂
∂
r
F
t
ϕ ϕ
            ( 4 . 1 0 )  
where F is the extended velocity field, here extended off the tumor boundary such 
that it is constant on normal rays to the tumor boundary; as a consequence of the 
  25spherical symmetry, the extended velocity everywhere is then taken equal to the 
normal velocity of the tumor boundary: 
) (T r r T r
U
W F = ∂
∂
− =               ( 4 . 1 1 )  
The initial level set function is given by  0 ) 0 , ( R r t r − = = ϕ . To update the time-
dependent level set function ϕ , a simple explicit first order scheme in time 
(forward Euler) and space is used to discretize the level set equation (4.10) (refer 
to Section 5 for more information). The spatial derivative in (4.11) is 
approximated using second order backward differencing 
( is discontinuous across the interface). With the level set 
function updated, the new location of the interface is estimated as the zero level 
set by linear interpolation of the new level set function. 
C C D T U U U U U ˆ + + + =
•  The set of model governing equations (4.3) is discretized using forward 
differencing in time and regular second order centered differences in space both 
for the second and for the first order derivatives at all the internal mesh except the 
ones adjacent to the boundary. At points adjacent to the boundary, the spatial 
discretization must be modified to take into account the location of the boundary 
and the model prescribed boundary conditions. As already mentioned, this is 
accomplished by constructing local second order interpolating polynomials for 
each of the model dependent variables  ,  ,  ,   and   respectively; 
then their second order derivative at a point adjacent to the boundary is 
approximated as the second order derivative of the corresponding polynomial; 
similarly for the first order derivatives.  
A U C U T U D U N U
  26To update the current values of the state variables at the interface – which are to 
be used at the next time step in constructing the local second order interpolating 
polynomials at points adjacent to the boundary - the continuity of  ,  ,  A U C U
r
U A
∂
∂
and 
r
UC
∂
∂
 at the tumor boundary is first used to determine the current values 
of   and   respectively at the interface; once the value for   is known at the 
current time step, then the model boundary conditions (2.16) are used to update 
the values of   and   at the interface at the current time step. 
A U C U C U
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Details can be found in Appendix A. 
 
4.3 Numerical results  
 
4.3.1  Numerical results from a computational point of view 
 
The first aspect to be addressed is the usage of centered finite differences to 
approximate the first order derivatives in equation (4.3). If an heuristic stability 
assessment is conducted for each of the model equations (2.12) and (2.15) considered 
separately [30], then potential stability problems may arise if the advection terms 
dominate diffusion terms. An estimate for the magnitude of the relevant model 
parameters is necessary to fully access the stability. For the parameters considered here, 
the diffusion type constraint on the time-step imposed by the first equation in (2.12) will 
generally dominate the advection-diffusion type constraint for the second equation in 
(2.12). Under these conditions, the use of centered finite differences in approximating the 
  27first order derivatives is relatively safe. Numerical experiments support this conclusion. 
However, to investigate model behavior in regimes characterized by drift coefficients 
(e.g.,  ) substantially larger than the model diffusion coefficients, then upwind schemes 
must be used to discretize the first order spatial derivatives in the second equation (2.12). 
C W
    A second aspect of computational concern is the treatment of the terms involving the 
Heaviside function in the first and second equation (2.15). It is common to smear out the 
Heaviside function for computational implementation purposes by defining: 
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u H + ≈             ( 4 . 1 5 )  
with ε  a small value (typically,  ) (h O = ε , where   represents the spatial mesh size).   h
However, in our numerical experiments performed so far, by comparing the results 
obtained using the actual Heaviside function and the smeared out version given by (4.15), 
no significant differences were detected.  
     Another important aspect is the choice of the larger fixed computational domain – 
because of the boundary conditions (2.13). In the spherically symmetric case (i.e., 1D), it 
is easy to employ a radius for the fixed outer domain considerably larger than the initial 
radius of the tumor – such that both the density of TAF   and the density of the new 
capillaries   naturally decay to zero towards the outer domain boundary. In higher 
dimensions, the choice of the domain size for the outer environment is more restricted. 
Numerical tests performed in the spherically symmetric case (and in 2D) have 
demonstrated the requirements on the choice of the outer boundary location. 
A U
C U
    Fig.1 shows a comparison between the tumor radius in time obtained via the pseudo-
Lagrangian method described in section 4.1 and the tumor radius in time obtained via the 
  28Eulerian/level set method described in section 4.2 for the following choice of the model 
parameters (2.19): 
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The spatial mesh size in the pseudo-Lagrangian method is  02 . 0 = ∆ = ∆ η ξ  with a fix 
time-step  , while in the Eulerian/level set method 
5 10 66 . 2
− × = ∆t 05 . 0 = ∆r  with the 
time-step chosen adaptively (obeying stability restrictions). These choices for the mesh 
sizes, initially balances the number of mesh points inside the physical domain occupied 
by the tumor for the two methods (the resolution remains balanced during a reasonable 
portion of the tumor evolution). The results show very good agreement between the two 
different solution methods. 
 
4.3.2 Numerical  results  from a biological viewpoint 
 
  29All the results discussed in this section are obtained using the above set (4.16) of model 
parameters as base values. Any parameter variation is explicitly defined when presenting 
the results. 
 
i.  Evolution of the tumor radius in time 
In Fig.1 two different stages of tumor growth can be clearly distinguished: up to time 
, the growth is linear, at a relatively low rate – corresponding to the avascular 
stage; at later times, the growth is accelerated, exhibiting exponential trends – 
corresponding to the vascular stage. Fig. 2 shows the behavior of the tumor radius in time 
in the absence of tumor-induced angiogenesis, for two different values of  : the solid 
line corresponds to a value of 
84 . 1 ≈ t
D ∆
001 . 0 = ∆D  and the dashed line to  1 = ∆D ; the rest of the 
model parameters are as in (4.16) above. In the case of the large disintegration rate 
 for the tumor dead cells, the tumor radius shows stabilization to a limiting value 
of  around time  , while in the case of the small disintegration rate  
approach to a stabilized state is not yet apparent up to time 
1 = ∆D
3 ≈ R 10 = t 001 . 0 = ∆D
20 = t . This is in good 
agreement with the argument made in [11], that ultimately a balance between the living 
tumor cells and the dead tumor cells – reached when the proliferation of cells near the 
tumor surface balances the disintegration of dead cells in the necrotic region – determines 
a stationary radius of the avascular tumor.  For the same value of the drift coefficient 
, smaller values of    lead to a larger stationary radius of the tumor and a larger 
necrotic core with respect to the proliferation rim. 
T W D ∆
 
ii.  Tumor living and dead cell density evolution 
  30Fig. 3 plots the tumor living cell density   versus the radial coordinate  T U r  at various 
moments in time. The avascular and the vascular stages of growth are clearly 
differentiated here as well; in the avascular phase,   decreases towards the center of the 
tumor because the living tumor cells start to gradually die when they lack nutrients – this 
is confirmed by the corresponding evolution of the dead tumor cell density shown in Fig. 
4; further, in the vascular phase, it is observed that the living tumor cell density continues 
to rapidly drop towards the center – while the dead cell density,  , there remains 
stationary (note that the model assumes dead tumor cells do not move). In the model, 
living tumor cells towards the center stop dying, and migrate towards less populated areas 
where they have a higher probability to survive and eventually continue the mitosis 
process if the levels of nutrients are high enough. In Fig. 6, the overall cell density, 
, is plotted at specific times; the curves show that once the new 
capillaries penetrate the tumor and begin to influence its center there will be a rapid 
increase of the overall cell density. Since the tumor size is relatively small here and the 
upper threshold for the new capillaries is high, while their death coefficient is much 
smaller than the growth coefficient, this happens relatively fast. The rapid increase in 
overall cell density leads to sharper local gradients, that in turn lead to fast movements of 
the living tumor cells towards the outer tumor region; in particular, there is a significant 
increase in the slope of the overall tumor cell density at the boundary of the tumor. Recall 
from Eqn (2.18) that the velocity of the tumor boundary is directly proportional to the 
gradient of the overall cell density. 
T U
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iii.  New capillary cell evolution 
  31The evolution of the new capillaries is depicted in Fig.5. To facilitate the simulation, a 
large value for the growth coefficient  C Γ  was chosen while the death coefficient  C ∆ is 
small. In addition, the drift coefficient,  , is five times larger than the diffusion 
coefficient,  . These parameters yield significant movement of the new capillaries 
towards the source of angiogenic stimulus (TAF), which is maximum inside the domain 
occupied by the tumor. In the model, the density of new capillaries is allowed to reach an 
upper threshold 
C W
C K
1 = C U , which is the close packing density for the overall cell density, so 
the resulting scenario is not totally realistic. However, the choice of parameters related to 
the growth of new capillaries (which is, in fact, the core of the tumor vascularization 
problem) allows for the overall development of visible and meaningful changes over a 
relatively short period of time. 
 
iv.  The TAF and nutrient concentration  evolution 
The TAF distribution along the radial coordinate at various times is shown in Fig. 7. In 
the present version of the model, it is assumed that the living tumor cells constantly 
produce and release TAF, which diffuses at the same constant rate both inside the tumor 
and in the surrounding outer environment. Because of this assumption and the fact that 
the TAF decay parameter is chosen small ( 01 . 0 = ∆ A ) for the case considered, the 
evolution equation for TAF (the first equation (2.12)) is a linear diffusion equation with a 
source term with vanishing boundary conditions. As a result, the TAF concentration 
maintains a maximum at the tumor center.  
    The nutrient evolution is presented in Fig.8. Fig.8(a) shows the radial distribution of 
the nutrient at various times during the avascular phase. The nutrient reaching the tumor 
  32surface diffuses inside the tumor;. Since the evolution equation for the nutrient inside the 
tumor (the last equation (2.15)) is a diffusion equation with a sink term, the levels of 
nutrient maintain a maximum at the tumor boundary and gradually decrease towards the 
tumor center. As a consequence, living tumor cells first start dying at the center, while a 
layer of cells adjacent to the boundary are able to proliferate. Fig.8(b) shows the nutrient 
evolution at later times, in the vascular phase; with the accelerated development of new 
capillaries, increased amounts of nutrients reach the tumor surface and diffuse inside the 
tumor at a rate increasing proportionally to the new capillary density. This explains why 
the tumor dead cell density remains almost stationary from a point on (the level of 
nutrient becomes sufficient for the remaining living cells). 
 
 
5.  Description of the general numerical algorithm and discretization procedures 
 
  5.1 Construction of the “extension velocity” field off the interface 
 
  One way of extending the normal velocity off the interface in the level set 
equation (3.3) is extrapolation in the normal direction, following characteristics that flow 
outward from the interface, such that the velocity is constant on rays normal to the 
interface. This method, introduced by Malladi, et al. [23] works particularly well when no 
other information is available except for what is known on the interface–as is the case 
here. At points adjacent to the interface, on each side, the “extension velocity” field  is 
first constructed as follows: standing at a grid point adjacent to the interface, either inside 
F
  33the domain occupied by the tumor or outside, locate the closest point on the interface 
whose velocity is given by Eq. (2.18) – with second order backward differencing in the 
normal direction used to numerically approximate the normal derivatives – and copy its 
velocity. Construction of the extension velocity field in this manner has the advantage 
that it tends to preserve the signed distance function during the interface evolution in 
time. A fast way of building these extension velocities in the context of Dijkstra's-like 
algorithms was provided by Adalsteinsson and Sethian in [2]. An alternate way to 
formulate this construction is by employing a pair of linear Hamilton-Jacobi equations 
[26], in which the velocity values at the adjacent points are subsequently kept fixed and 
framed as boundary conditions for the following: 
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where the local unit outward normal in the level set methodology is defined everywhere  
as:  
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Here τ designates a pseudo-time for the relaxation of the equations to steady-state at each 
moment of time t. Equations (5.1) and (5.2) are numerically discretized using a regular 
first order upwind scheme [22],[26] and iterated to steady-state, where the corresponding 
solution ) ,t x ( F F
r
= will be constant on rays normal to the interface.  
    The normal  ) , ( t x n n
r r r
=  in (5.3) is approximated using the construction described in 
[31]; the local unit outward normal at a point on the interface - which generally is not a 
  34grid point - is obtained by bilinear interpolation from the values of the local unit outward 
normal computed at the four neighboring nodes on the fixed Cartesian grid. 
 
5.2 Re-initialization of the level set function ϕ  
 
   As discussed by Chopp [13], in general, a procedure is needed to reset the level 
set function ϕ  as a signed distance function to the interface (in this case, the tumor 
boundary) from time to time. Re-initialization at some moment of time   can be regarded 
as the process of replacing the current level set function 
t
) , ( t x
r
ϕ  by another function 
) , ( t x
reinit r
ϕ  that has the same zero contour but is better behaved;  ) , ( t x
reinit r
ϕ  becomes the 
new level set function to be used as initial data until the next re-initialization. 
Reinitialization and its role in Narrow Band Methods was first analyzed in depth by 
Adalsteinsson and Sethian in [2], and a very fast Dijkstra-like method to perform this 
reinitialization was given by Sethian in [34]. 
Another way of re-initializing the level set function ϕ  to a signed distance function to the 
interface employs the following “re-initialization equations” [26]: 
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with   
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  35Here again, τ designates a pseudo-time for relaxing the equation to steady-state at a fixed 
real time  . As before in the case of the extension velocity, first at grid points adjacent to 
the boundary, on each side,   is reset close to a signed distance function by hand (a 
very efficient way is the initialization stage of the fast marching method in [31]). These 
values are subsequently kept fixed and framed as boundary conditions for the equations 
(5.4) and (5.5) respectively, that are individually solved to steady-state. The resulting 
solution 
t
reinit ϕ
) , ( t x
reinit r
ϕ  will be a signed distance function to the interface   at the 
particular time t in the model evolution.  
) (t Σ = Σ
    The  implementation  of  the  level  set  methodology is presented here for the two-
dimensional case, but the extension to three dimensions is straightforward. The domain 
occupied by the tumor Ω is embedded into a larger fixed, time-independent, 
computational domain D, that is discretized using a uniform Cartesian mesh with 
 The region outside of the tumor is denoted by  . h y x = ∆ = ∆ = Ω
out D . The tumor 
boundary will also be referred to as the “interface” – separating the domain occupied by 
the tumor from the outside tissue. A “regular” grid point (either inside the domain 
occupied by the tumor or outside) shall denote a point on the fixed Cartesian grid that has 
no neighbors on the tumor boundary, in either the horizontal (
Ω \
x) direction or the vertical 
( ) direction, while an “irregular” grid point (on each side of the tumor boundary) 
corresponds to a point on the fixed Cartesian grid that is adjacent to the boundary, either 
horizontally or vertically. 
y
 
  5.3 Discretization of the level set equation and the re-initialization equation 
 
  36The level set equation (3.3) is discretized using a conservative scheme for 
nonlinear Hamilton-Jacobi equations with convex Hamiltonian [31]: 
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and ( ) stands for the backward differencing approximation of the first-order 
partial derivative in the x (y)–direction, while  ( ) stands for the forward 
differencing approximation. The above scheme is a first order (forward Euler) in time; 
higher order schemes such as HJ ENO or WENO can be employed [26]. The time step in 
(5.7) must obey the CFL condition for stability: 
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A similar scheme is used to discretize the re-initialization equations (5.4) and (5.5). 
 
  5.4  Overall numerical solution procedure 
 
The governing model equations are discretized using explicit finite difference 
schemes, which enables straightforward implementation. Details of the numerical 
  37solution procedure for the model dependent variables are given in Appendix A. A 
comparison of spatial discretization schemes for the level set equation and a discussion of 
the approximation error is given in [17]. Here, the global solution algorithm is outlined 
briefly in terms of the following steps: 
 
1)  It is assumed that all the model dependent variables:  ) , ( t x U A
r
, ) , ( t x UC
r
,  ) , ( t x UT
r
, 
,  ) , ( t x UD
r
) , ( t x UN
r
 (all initially given by the model initial conditions (2.14) and (2.17)) 
along with the level set function  ) , ( t x
r
ϕ  are known at timet, with the level set function 
equal to the signed distance function (prescribed initially, or as a result of re-initialization 
at later times). As a result, the current location of the interface is implicitly known.   
Following [1], a “narrow band” (tube) is built around the interface, with a user-prescribed 
width. Since  ) , ( t x
r
ϕ  is assumed close to a signed distance function, the narrow band is 
defined by locating the points using the following criterion: 
         {} T width t x x
not.
) , ( = <
r r
ϕ .  
The grid points inside the tube and the grid points near the tube edge are marked 
distinctly.  
 
2) With the value of  ) ( ˆ ) , ( ) , ( ) , ( ) , ( x U t x U t x U t x U t x U C C D T
r r r r r
+ + + =  known at the time 
step  , the “extension velocity” field  t ) , ( t x F F
r
=  is constructed as described in Section 
5.1, at points   inside the narrow band tube  x
r
T . 
 
  383)  With the extension velocity field computed at points inside the tube T , the level set 
equation (5.7) is solved inside the tube to update the level set function at the next time 
step. The values of the level set function at grid points distinctly marked near the tube 
edge in Step 1 are frozen, as well as the values of the level set function outside the tube 
T .  The following conditions are monitored: 
 
a)  whether the newly updated tumor boundary (interface) approaches  the tube edge 
to within a specified tolerance (if so, then the values kept frozen in Step 4, which 
serve as artificial numerical boundary conditions, will severely affect the actual 
location of the interface);  
b) whether steep or flat gradients are developing in the newly updated level set 
function, particularly at points neighboring the interface. 
 
4) With the new location of the boundary implicitly captured by the updated level set 
function ) , ( t t x ∆ +
r
ϕ , the model governing Eqs. (2.12) and (2.15) along with the 
corresponding prescribed boundary conditions (2.13) and (2.16) are employed to compute 
the new values of the model dependent variables:  ) , ( t t x U A ∆ +
r
, ) , ( t t x UC ∆ +
r
, 
,  ) , ( t t x UT ∆ +
r
) , ( t t x UD ∆ +
r
, ) , ( t t x UN ∆ +
r
 as described in Section 5.4 . 
 
Steps 2-4 are repeated until either situation a) or b) occurs; when this happens, the narrow 
band (tube) T must be rebuilt and the procedure begins with Step 1 again. Employing this 
narrow band level set method is computationally very efficient (especially in constructing 
  39the extension velocity field); this approach is ideal when only the evolution of the 
interface itself is of interest (i.e., the zero level set), as is the case here.  
 
6.   Numerical results in two dimensions – arbitrary geometry 
 
6.1 Computational  Details 
 
The numerical simulations presented here were obtained by employing 
straightforward finite-difference schemes. The motivation was to create a framework that 
could be easily implemented to study a variety of tumor growth models. For the present 
model, since no curvature effects at the tumor boundary are incorporated, we find that a 
first-order spatial scheme in the level set equation (5.7), as well as in the re-initialization 
equations (5.4), (5.5) can be safely used. For the same reason, the size of the narrow band 
(tube) T can be relatively modest – here a width of   on each side of the interface is 
chosen and the interface is only allowed within at most 2 grid cells from the tube 
boundary (i.e., it is allowed to move at most 4 grid cells within the tube) before the tube 
is rebuilt. As in [17], re-initialization is typically used jointly with re-building the narrow 
band. They also determined that the forward Euler time integration scheme for the level 
set equation (5.7) was sufficient; particularly since the time step is small due to the 
overall fully explicit nature of the solution procedure. 
h 6
    Regarding the choice of the “small” value ε  in the ε -test (see Eq. (A.5) in Appendix 
A), since the actual location of a boundary point is found by linear interpolation of the 
level set function at the neighboring grid points, one natural consistent choice for ε  is 
  40) ( ~
2 h O ε ; the results in the spherically symmetric case via the Eulerian/level set 
approach in Section 4 are obtained by using  . However, this choice is related 
strictly to the spatial accuracy of the numerical approximation, and has no apparent 
geometrical interpretation; in the context of Eq. (A.5), the geometrical location of a 
boundary point (either in the horizontal or in the vertical direction) is in-between two 
Cartesian grid points, and the actual measure of how close one of the two grid points is to 
the boundary point is given by a fraction of the grid size  . In our numerical experiments 
we found that a good choice for 
2 h = ε
h
ε  is  N h/ = ε , with N an integer that depends on the 
geometrical properties of the front involved. If no curvature effects are present – as in the 
current model – then  5 / h = ε  was found to work well. This is demonstrated by the 
results shown in Fig. 9, where the initial tumor boundary is taken to be a circle centered 
at the origin with radius 1, and the support of pre-existing capillaries is a circular area 
surrounding the initial tumor:  } 3 . 2 2 ) , {(
2 2 < + < = y x y x S . The set of model 
parameters (4.16) is used, but with the pre-existing capillary density taken five times 
larger, to speed up the calculations (  inside S ). A comparison is performed 
between the tumor radius evolution obtained by three different sets of calculations: the 
two-dimensional Cartesian level set approach described in Section 5, the one-dimensional 
Eulerian/level set approach described in Section 4.2 (under the assumption of polar 
symmetry) and the one-dimensional pseudo-Lagrangian method described in Section 4.1 
under the assumption of polar symmetry as well. For the 2D method, the fixed Cartesian 
mesh size is  , the computational domain (outer environment) is 
5 . 0 ˆ = C U
05 . 0 = h ] 4 , 4 [ ] 4 , 4 [ − × −  
and the time step is adaptive; in the 1D Eulerian/level set method, the mesh size is 
  4105 . 0 = ∆r , the radius of the outer environment is  4 = D R and the time step is adaptive; in 
the 1D pseudo-Lagrangian method, the mesh size is  04 . 0 = ∆ = ∆ η ξ  and the time step is 
. The results demonstrate that the two-dimensional problem formulated in 
Cartesian coordinates in this case exhibits genuine polar symmetry while in the avascular 
phase of the tumor growth (see model equations (2.15) – (2.17)), but it gradually starts to 
depart from it with the increased development of new capillaries in the subsequent 
vascular phase. This is due to the geometric computational configuration of the outer 
environment in Cartesian coordinates, which is a fixed square box, and not a circle (how 
long the assumption of full polar symmetry can be employed depends on the size of the 
fixed Cartesian computational box relative to the tumor radius). There is very good 
agreement for the growth rate between the three sets of results up to time  (which 
corresponds to the avascular phase of growth); the agreement continues to be good 
(within the overall accuracy of the methods) up to time 
5 10 4 . 6
− × = ∆t
5 . 0 ≈ t
9 . 0 ≈ t . Eventually, the two-
dimensional Cartesian result no longer compares to the one-dimensional results obtained 
under the assumption of full polar symmetry. 
     Similarly with the argument made in [17], when computing the normal velocity of the 
tumor interface via Eq. (2.18), a second-order accurate backward difference 
approximation in the normal direction is found optimal here as well. If the field variables 
,   and   are numerically computed with second-order spatial accuracy, then the 
numerical estimate of the normal velocity of the interface can only be at most first-order 
accurate. Thus, it is to be expected that the location of the tumor boundary can be found 
at most with first-order spatial accuracy.  
T U D U C U
  42    All the results that follow are obtained within the framework of the general Eulerian 
level set/Cartesian grid methodology described in Section 5 above. In Fig. 10, the results 
of a convergence study are shown. The tumor initial boundary is given by the 4-fold 
symmetrically perturbed circle: 
] 2 , 0 [ )), sin( ), ))(cos(
4
4 sin( 4 . 0 )
4
4 cos( 4 . 0 8 . 4 ( )) ( ), ( ( π α α α
π
α
π
α α α ∈ + − + − = y x  (6.1) 
The same model parameters as in Fig. 9 above are used. Outside the domain occupied 
initially by the tumor there are four fixed circular seeds of pre-existing capillaries, 
symmetrically positioned and relatively close to the boundary of the outer environment. 
This initial configuration will be described in more detail below. The evolution of the 
tumor boundary computed using three different mesh sizes:  4 . 0 = h ,   and  2 . 0 = h 1 . 0 = h  
is shown at three different moments of time and the qualitative convergence can be 
observed. The mesh sizes were chosen to allow for two levels of refinement, starting with 
a reasonable mesh spacing. Currently, the methodology developed here is designed for 
implementation on moderately sized, standalone computing platforms. Moderate mesh 
resolution, relative to the initial tumor size, was used to evaluate the solution behavior 
and determine whether the results show the correct qualitative trends.. Through numerical 
testing, it was found that the location of the tumor boundary was not very sensitive to the 
spatial mesh size, when the value of the drift coefficient   equal to 10 or smaller, since 
there is no curvature effect at the boundary in the current model. In [17], where the tumor 
boundary curvature was important, for drift coefficients of the same order of magnitude, 
considerable sensitivity to the spatial resolution was found. 
T W
    The accuracy of the tumor boundary location in time can be quantitatively estimated 
[17]. The level set method reconstructs the interface at every moment of time as a 
  43piecewise linear manifold; suppose that the Cartesian mesh size is doubled twice and 
denote by 
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 at time  n t t = corresponding to the coarsest mesh, the 
intermediate mesh and the finest mesh, respectively. Thus, the interface is represented as 
a polygonal line with  ,   and   line segments for the coarsest, intermediate and 
finest representation, respectively. Each polygonal line can be re-divided into the same 
given number 
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        Since no analytic solution is available, the errors are computed with respect to the 
numerical solution corresponding to the finest mesh 
N k
n
k erface X
, 1
4 ,
, int } {
=
r
; following [18], the 
error at time   is defined as the largest Euclidean distance of the corresponding 
points of the two computed interfaces: 
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  44A ratio   between 4 and 5 typically indicates second-order spatial accuracy, 
while a ratio between 2 and 3 typically indicates first-order spatial accuracy [18]. The 
quantitative errors resulting from the mesh refinement analysis in Fig. 11 are recorded in 
Table 1. According to these values, the tumor boundary location using the fixed Cartesian 
mesh, ”narrow band” level set approach developed here is found with first-order spatial 
accuracy during its evolution in time. 
n n e e 2 _ 4 1 _ 4 /
 
Table 1. 
time  n e 1 _ 4 (6.2) 
n e 2 _ 4 (6.3) 
n
n
e
e
2 _ 4
1 _ 4  
t=0.353  0.0584 0.0319 1.83 
t=0.8236  0.1263 0.0614 2.058 
t=1.1766  0.2839 0.1036 2.74 
 
 
6.2  Model Behavior 
As discussed in Section 4.3.2, the numerical results presented for both the 
spherically symmetric and two-dimensional cases correspond to computationally optimal 
conditions for the tumor vascularization (i.e., increase in new capillary density) as 
predicted by the model. The model parameters (2.19) chosen for the simulations here 
enable readily visible and significant changes in the tumor growth process over a 
relatively short period of time. For more moderate choices of these parameters 
(particularly in the equation for the new capillary density), the current model yields long 
and slowly evolving avascular stages of growth, before the tumor begins to develop its 
  45own capillary network. During the avascular stage the growth is stable, with a linear rate 
of growth initially, that decreases asymptotically to zero. It is the vascularization of the 
tumor via the tumor induced angiogenesis contained in the model that leads to more rapid 
and unbounded growth. From a computational standpoint, the stability requirements due 
to the fully explicit nature of the numerical scheme lead to certain practical bounds on the 
choice of the model parameters used in the actual simulations.  
    For the 2-D simulation results presented in Figs.11 and 12, the same set of model 
parameters used for the case shown in Fig. 9 was used. In Fig. 11(a), the evolution of the 
tumor with the initial boundary given by Eq. (6.1) is shown in detail. Outside the domain 
occupied initially by the tumor there are four circular seeds of pre-existing capillaries, 
symmetrically positioned and relatively close to the boundary of the outer environment; 
their location is marked by the small gray circles, of centers: (6,6), (-6,6), (-6,-6) and (6,-
6) respectively, and radius 1.2; the Cartesian mesh size  1 . 0 = h , the computational 
domain (outer environment)  ] 8 , 8 [ ] 8 , 8 [ − × −  and the time step is adaptive. The initial 
tumor boundary is deliberately chosen as a circle symmetrically perturbed towards the 
location of the pre-existing capillaries. Up to time  6 . 0 ≈ t  the tumor is in the avascular 
phase−the growth is very slow, stable and self-similar. At time  9 . 0 ≈ t , corresponding to 
an intermediate to moderate degree of tumor vascularization, instability starts to become 
evident as the initially perturbed tumor boundary grows more towards the location of the 
pre-existing capillaries, exhibiting a tendency to elongate. However, at later times, in a 
high vascularization phase, the elongation is less apparent and the tumor continues to 
expand rapidly but in a relatively uniform manner. The explanation of the growth 
behavior is found in the corresponding evolution of the new capillaries, depicted in Fig. 
  4611(b), where both a contour map(11b-1) and a surface plot(11b-2) of the new capillary 
density are included. It can be seen that the endothelial cells stimulated initially are the 
ones  belonging to the pre-existing capillaries. At early times, since the new capillaries 
have not evolved sufficiently to reach the tumor, it remains in the avascular phase and the 
slow stable growth occurs as described above. An intermediate stage of vascularization 
follows when enough new capillaries have developed outside the tumor in the regions 
neighboring the location of the pre-existing capillaries, such that they undergo a strongly 
oriented movement towards the source of angiogenic stimulus – the tumor itself. It is in 
this stage that the tumor exhibits the tendency to elongate towards the location of the pre-
existing capillaries. At later times, once the newly formed blood vessels (characterized by 
the capillary density) have reached inside the tumor, they are in turn stimulated to 
proliferate, and a faster tumor vascularization follows (due to the fact that the TAF values 
are much higher inside the tumor than outside, coupled with the large value of the growth 
coefficient,  ). Eventually, the new capillary distribution tends to level-off 
spatially leading to subsequent quasi-uniform growth of the tumor. 
100 = ΓC
    Contour maps of the tumor living cell density are shown in Fig. 11(c). In the avascular 
phase of the tumor growth, a rim structure develops as described in [11]. The results 
show a very thin outer rim of proliferative cells, followed by a slightly thicker adjacent 
rim of quiescent cells–cells that live but do not proliferate. The inner tumor region shows 
a smooth transition towards a large necrotic core. The choice of the nutrient threshold 
values  9 . 0 ~ 8 . 0 = < = N N U U  in (4.16) allows for the existence of a quiescent rim of 
living tumor cells (a tumor region where the nutrient levels reaching the existent living 
  47cells are such that  N U T U N U N U
~
/ < < ). The smooth transition towards a large necrotic 
core is confirmed by the evolution of the tumor dead cells shown in Fig. 11(d). 
    The distinct patterning in the living and dead cell densities at later times results from 
the development and the subsequent spatial distribution of the new capillaries. A local 
increase of the new capillary density affects the value of the living cell density on the 
tumor boundary due to the given boundary conditions. Inside the tumor, local gradients 
of the overall cell density U develop and the living tumor cells are redistributed 
accordingly.  The pattern of the living tumor cells in turn impacts the pattern of the dead 
cells; moreover, since the disintegration coefficient of the dead cells in these simulations 
is taken very small (  ), the dead cells subsequently continue to have an 
important contribution to the overall cell density U From the evolution equations for the 
living and dead cell density, if enough cells die in a certain area, then the nutrient may be 
sufficient for the remaining living cells. 
001 . 0 = ∆D
    Fig. 11(e) shows contour maps of the TAF concentration level. As in the 1-D case, it 
has a maximum at the tumor center and decreases rapidly at the outer boundary of the 
tumor (refer to the comments in the spherically symmetric case). Finally, in Fig. 11(f) 
contour maps of the nutrient distribution inside the tumor are shown. Because significant 
amounts of nutrient are consumed by the living tumor cells adjacent to the tumor 
boundary, the nutrient level decreases considerably towards the central region, which 
leads to the large area of dead cells in the center region of the tumor. Another notable 
aspect here is the manner in which the levels of nutrient reaching the tumor boundary 
increase with the development of new vasculature in the vascular phase of growth. 
  48    For the results presented in Fig.12, the initial configuration considered previously in 
Fig. 11 is geometrically scaled down by a factor of 4. Both the size of the tumor and the 
radius of the pre-existing capillary regions are reduced. The domain occupied initially by 
the tumor is given by: 
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4
4 sin( 1 . 0 )
4
4 cos( 1 . 0 2 . 1 ( )) ( ), ( ( π α α α
π
α
π
α α α ∈ + − + − = y x    (6.4) 
while the four symmetric circular seeds of pre-existing capillaries (their locations marked 
by the four gray circles in Fig.12(a)) are located in a similar position relative to the outer 
domain border as in the previous case, but their center position is scaled by a factor of 4. 
The comparison between the two cases illustrates some interesting differences in the 
tumor evolution due strictly to size and geometry as predicted by the model. The same set 
of model parameters is used in both cases. The individual graphs in Fig.12 are organized 
in the same manner as Fig. 11 for comparison purposes. Fig.12(a) shows the evolution of 
the tumor beginning with the initial boundary given by Eq. (6.4). Up to time   the 
small tumor is in the avascular phase; around that time, as characterized by the density , 
  shown in Fig.12(b), newly formed capillaries start to reach the tumor surface. 
However, the new capillary density remains relatively small up to time   (low 
vascularization regime), such that in this phase the growth is very slow, stable, and 
remains self-similar. At later times, in the fully-developed vascular phase, the tumor 
expands fast in a relatively uniform manner. Unlike the previous case, the extension of 
the tumor boundary towards the location of the pre-existing capillaries is not apparent. 
An explanation can be found in the corresponding evolution of the new capillary density 
as depicted in Fig. 12(b), again shown both as surface plots and contour maps. The tumor 
size in this case is smaller, which leads to lower levels of TAF inside the tumor and, as a 
4 . 0 ≈ t
C U
6 . 0 ≈ t
  49consequence, lower levels of TAF reaching outside to stimulate the pre-existing 
capillaries to proliferate (see Fig. 12(e)); therefore, the density of the new capillaries is 
proportionally lower. In the present case, the distances between the pre-existing 
capillaries locations are 4 times smaller and the tumor boundary is 4 times closer to the 
pre-existing capillaries. As a result, diffusion leads to a substantially more uniform spatial 
distribution of the new capillary density in the intermediate vascularization phase than in 
the previous case of the larger tumor. Since the tumor size is smaller in the second 
simulation example, the model illustrates how new capillaries penetrate and reach the 
tumor central region faster than in the first example, such that the density of the new 
capillaries in the high vascularization phase exhibits a visible peak at the tumor center. 
    The spatial distribution of the tumor living cells in the second example, Fig. 12(c), is 
less interesting than in the previous case. The rim of quiescent cells in this case is 
considerably wider relative to the tumor size than before. An examination of the 
evolution of the dead cell density, Fig.12(d), suggests that the same comments made in 
Section 4.3.2 for the spherically symmetric case regarding the evolution of the tumor 
cells hold here as well. The central tumor region in transition towards a necrotic core is 
small in this case, and much less dynamic than in the previous case for the larger tumor, 
where the living tumor cell density exhibits highly varying spatial re-distributions in the 
vascular phase, Fig. 11(c). 
    Finally, the following aspects are worth considering regarding the comparison between 
the simulations for the large tumor and its small replicate: the larger tumor expands more 
slowly than the smaller one during their corresponding avascular phase. This is correct 
from a biological viewpoint, since in the avascular phase, a tumor can only reach a 
  50certain limiting size corresponding to a quasi-equilibrium state, where a balance is 
eventually achieved between the tumor living and dead cells. Under identical actual 
growth conditions (translated here into identical model parameters and initial conditions), 
in the absence of vascularization, the larger tumor is expected to approach a stabilized 
state faster. On the other hand, once the vascular phase occurs, the model correctly 
predicts a subsequent tumor expansion−more aggressive in the case of the large tumor−at 
increasingly higher normal velocities. 
        Lastly, the case of an initially asymmetric tumor boundary is considered with the 
following initial tumor boundary: 
] 2 , 0 [ )), sin( ), ))(cos( 6 sin( 07 . 0 ) 5 cos( 04 . 0
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          (6.5)  
The location of the pre-existing capillaries is a disk of center (1.5,1.5) and radius 0.3. The 
initial profile is marked by the small dashed gray circle in Fig.13. The density of the pre-
existing capillaries is constant and set at 0.4. The model parameters (4.16) were used, 
except for  4 . 0 = C U  and  . The Cartesian mesh size is  10 = N K 1 . 0 = h , the computational 
domain (outer environment) is  ] 4 , 4 [ ] 4 , 4 [ − × −  and the time step is adaptive. The 
evolution of the tumor boundary in time is shown in Fig.13 at equal time increments of 
0.25 up until time  , when the support of the pre-existing capillaries has been 
entirely engulfed by the advancing tumor boundary. As before, the evolution of the tumor 
corresponding to the avascular phase is slow and stable, in self-similar shapes. At later 
times, in the vascular phase, the self-similarity is lost in a quasi-uniform manner.  
5 . 2 = t
    For the final set of results presented, the effect of varying the model parameters   
(that characterizes the dependence of the nutrient diffusion rate inside the tumor on the 
N K
  51presence of capillaries) and   (characterizing the growth rate of the new capillaries) is 
investigated for the same initial tumor boundary given by Eq.(6.5). The same location 
and density for the pre-existing capillaries as in the previous case were used. A 
comparison of the tumor boundary evolution for three sets of parameter values is shown 
in Fig.14. The tumor boundary represented by the dotted line corresponds to the values 
 and  , the dash-dot line to 
C Γ
10 = N K 10 = ΓC 0 = N K  and  100 = ΓC  and the solid line to 
 and  . For all three cases, the tumor boundary is shown at time  10 = N K 100 = ΓC 5 . 2 = t . 
The results show that the tumor boundary evolution is much more sensitive to the value 
of the new capillary growth coefficient than it is to the nutrient diffusion coefficient 
through the capillaries. Inhibiting the nutrient diffusion through the capillaries inside the 
tumor (by setting   as opposed to  0 = N K 10 = N K ) leads to a moderate slowdown of the 
tumor expansion in time. By reducing the growth rate of the new capillaries one order of 
magnitude, a significantly higher reduction of the tumor size over time is achieved.   
Thus, with respect to a virtual treatment scenario (e.g., by the usage of drugs such as 
Angiostatin), a significant decrease of the capillary growth rate shows immediate and 
visible consequences on the tumor growth rate, slowing it down considerably in time.  
 
7.  Conclusions  
    A comprehensive multi-cell tumor growth model was successfully analyzed in detail 
using finite-difference solution techniques and an efficient narrow band level-set method 
to capture the evolution of the tumor boundary. The finite-difference discretization is 
particularly appropriate for this model, since the governing equations can be derived 
alternatively using a lattice-based approach [15] that directly yields a finite-difference 
  52type formulation. The continuum model incorporates the effect of angiogenesis in a 
deterministic fashion. It is well-established (Folkman, [16]), that tumor vascularization 
occurs through tumor-induced angiogenesis–the process where nutrient deficient living 
tumor cells release a chemical TAF (Tumor Angiogenic Factor). The TAF diffuses into 
the healthy surrounding tissue and stimulates the capillary network existent nearby 
outside the tumor, which leads to formation of new blood vessels through the 
accumulation of new endothelial cells. The new capillaries move towards the source of 
angiogenic factor leading to tumor vascularization. These important mechanisms 
associated with the angiogenesis phenomena are realistically incorporated in the present 
model, in a deterministic, macroscopic sense. The simulations presented both under the 
assumption of spherical symmetry as well as in arbitrary geometries in two dimensions 
confirm that the comprehensive model is able to capture both the avascular and the 
vascular phase of tumor growth, and to provide a quantitative tool for use in studying 
how and when this fundamental transition occurs. The progressive formation of a tumor 
necrotic core is captured as in many existing models for avascular growth, with the 
balance of proliferation and transport effects correctly varying according to the tumor 
size (large necrotic core for larger tumors, small necrotic cores for smaller ones). 
Moreover, the rim structure of the tumor in the avascular phase is well-exhibited, with 
rim size depending on the tumor size: for larger tumors, the proliferative and the 
quiescent rims are thin relative to the tumor size, while smaller tumors exhibit a thicker 
layer of quiescent cells. 
     While  the  overall  behavior  predicted by the model in arbitrary, two-dimensional 
geometries is reasonable, the model in its present form does not include effects that allow 
  53for more intricate tumor boundary evolution. Models have been developed which 
incorporate cell adhesion effects at the tumor boundary (Byrne and Chaplain, [7]). These 
models lead to a Gibbs-Thomson (or Young-Laplace) type of condition on the tumor 
boundary which relates the growth behavior to the curvature of the boundary. As is well 
known from inorganic phase boundary evolution, this type of condition leads to complex 
morphology in systems governed by diffusive transport. Clearly, more complex physics, 
soundly based on smaller-scale biological mechanisms, still needs to be incorporated in 
order to model tumor growth under more general conditions (e.g., conditions under which 
tumor boundaries exhibit “fingering” or more complex morphology). Since all the 
transport coefficients appearing in the model have been taken constant in the simulations 
so far (physically corresponding to a homogeneous, isotropic growth environment), the 
only potential source of “anisotropy” comes from the location of the pre-existing 
capillary network in the healthy tissue region neighboring the tumor. The numerical 
experiments so far tend to demonstrate that, while a more complicated arrangement of the 
pre-existing capillaries may yield more complex tumor boundary evolution in the 
intermediate/moderate vascularization regime, with constant transport coefficients 
morphological complexity is diminished in the high vascularization regime. In fact, this 
result is in good agreement with recent experimental results on in vivo tumors grown in 
an isotropic sponge-like matrix [14]. 
     As far as the computational framework developed here is concerned, the advantage is 
its generality and relative simplicity of implementation, which makes the implementation 
of different model features straightforward to incorporate. The formulation details 
presented here and in a companion article (Hogea, et al. [17]) provide a comprehensive 
  54description of the numerical procedure implementation. In the last five years, building on 
work over many years, a number of detailed tumor growth models have been developed 
that may be valuable tools for better understanding tumor growth and specific treatment 
regimes when implemented computationally. In order for this type of modeling to 
provide useful information from a medical research prospective, mechanically and 
biologically realistic models will have to be used for simulations in 3-D. The 
methodology developed here is readily adaptable to three-dimensional calculations from 
an algorithmic point of view. All the components of the numerical schemes involved 
extend to the three-dimensional formulation in a straightforward manner (often 
translating to simply adding one more dimension to the arrays involved). The 
straightforward finite-difference procedures are well-suited for parallel implementation, 
which is becoming the pervasive large-scale computing platform. Moreover, the level set 
method in the narrow band implementation has the ability of naturally capturing 
potentially large topological changes in the tumor boundary evolution in time at reduced 
computational expense, while automatically providing information about the local 
geometric properties. This is crucial for simulations of complex tumor growth where 
different biological phenomena may occur inside the tumor and outside in the healthy 
surrounding tissue. More accurate and less restrictive time integration schemes are one 
aspect where the current implementation has to be improved. This would enable more 
accurate studies of the model behavior over a broader range of model parameters. These 
schemes are currently under development and will be incorporated in future studies.  
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  59Appendix A   Discretization of the model equations 
Each of the model governing equations (2.12) and (2.15) can be cast in the general 
compact conservative form: 
) ( ) ( ) ( ) ( µ µ ν µ µ
µ
L W Q
t
− Γ + ∇ • ∇ − ∇ • ∇ =
∂
∂
     
For the reasons stated at the beginning of Section 4, the equivalent non-conservative 
formulation is employed for the implementation here:                                              
) ( ) (
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 In the solution formulation, the current time is  t n tn ∆ + = + ) 1 ( 1 , and the corresponding 
level set function is   at all Cartesian grid points  . The 
current domain occupied by the tumor is 
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n j i t ϕ  and  
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n j i t ϕ . As a result of the Eulerian nature of the solution 
methodology, coupled with the inherent discontinuities across the tumor boundary, it is 
necessary to identify and treat separately two types of grid points: 
 
1.  } 0 ) , {(
1
, , >
+ n
j i
n
j i j i ϕ ϕ  - referred to as “well-behaved” grid points - namely, grid points 
that remain on the same side of the tumor boundary during the time increment from 
 to  . At “well-behaved” grid points, the mass balance equation (A.1) is valid  n t 1 + n t
  60and the discrete solution   at the current time step is 
obtained by using a forward Euler time integration: 
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2.  } 0 ) , {(
1
, , ≤
+ n
j i
n
j i j i ϕ ϕ  - referred to “ill-behaved” grid points - namely grid points 
where the tumor boundary crosses over during the time step from   to  . At such 
“ill-behaved” points, a discontinuous change occurs during the time step and the 
mass balance equation (A.1) can no longer be employed; instead, the solution 
 at the current time step is obtained by interpolation. If the 
tumor boundary falls directly on a grid point at the previous time step, then it is also 
classified as “ill-behaved.” 
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In implementing this solution approach, it is assumed that the tumor boundary does not 
advance more than one mesh spacing in a time step – which is in fact required by the 
CFL stability condition (5.10) for the level set equation (5.7). As defined in Section 5, a 
“regular” grid point (either inside the domain occupied by the tumor or outside)  is a 
point on the fixed Cartesian grid that has no neighbors on the tumor boundary (in either 
the horizontal ( x) direction or the vertical ( ) direction) while an “irregular” grid point 
(on each side of the tumor boundary) corresponds to a point on the fixed Cartesian grid 
y
  61that is adjacent to the boundary, either horizontally or vertically. We note that “ill-
behaved” grid points can only be “irregular.” 
    At “regular” and “well-behaved” grid points, the standard 5-points stencil is used to 
discretize the Laplace operator in (A.2): 
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and similarly for  . Centered differencing is used to approximate the first order 
spatial derivatives in each direction: 
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and similarly for the term  . 
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    In the case of an “irregular” horizontal grid point  , where, for instance,   
and  , there is an interface point in the horizontal direction between   and 
 (label its location as  ). By linear interpolation of the level set function, the 
value of  can be determined as follows: 
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If  1 << ≤ ε θ h x , where ε  is a small number (typically, ε  is chosen relative to the grid 
size  ), then the grid point   can be considered on the interface (we refer to this as  h ) , ( j i
  62the ε - test).  More details on the actual choice of ε  in the actual numerical simulations is 
given in the results Section 6. If the “irregular” grid point   is also “well-behaved” 
according to the criterion introduced above, then a second-order interpolating polynomial 
 in the x-direction is constructed using   
where
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) ), ( , ( n b t j y x µ  is computed from the corresponding prescribed boundary 
conditions applied at the boundary point . Using this approach, the second 
derivative in (A.2) is approximated as 
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and the first derivative as  
  ) (
' , ) ( i x x
n
j i x p
x
= ≈
∂
∂
µ
µ
             ( A . 7 )  
The same procedure is used in the y-direction. Naturally, there will be “irregular” grid 
points that might have neighbors on the boundary both in the x- and y-direction. 
Similarly, individual second order interpolating polynomials are separately constructed 
for all the other model dependent variables involved in (A.2) and the corresponding 
spatial derivatives are approximated as in (A.6) and (A.7) above. 
     The general discussion on overall numerical stability presented in Section 4.3.1 holds 
here as well, with the constraint on the time step size dominated by the diffusion type 
terms (but now in two dimensions). 
    The model boundary conditions at every time step are handled here as follows: first, 
the continuity of the model dependent variables  ,   and of their associated fluxes – 
here translating into the continuity of their normal derivatives - across the tumor 
A U C U
  63boundary is employed to determine the actual values of   and   on the tumor 
boundary (the normal derivatives of  ,   on each side of the tumor boundary are 
approximated by using one-sided differences in the normal direction). With the value of 
 known on the boundary, the prescribed Dirichlet boundary conditions (2.16) are 
employed to compute the values of   and   on the tumor boundary. 
A U C U
A U C U
C U
T U N U
    Once the discrete solution   at the current time step has been 
computed at all the “well-behaved” grid points   - both “regular” and “irregular” – 
then the boundary values are updated as described above and finally, the solution   at 
the remaining “ill-behaved” grid points at the current time step is obtained by 
interpolation. The boundary value is employed if the grid point is close enough to a 
boundary point (according to the 
) ), ( ), ( ( 1
1
, +
+ = n
n
j i t j y i x µ µ
) , ( j i
1
,
+ n
j i µ
ε - test) otherwise bilinear interpolation is used. This is 
the most straightforward approach; higher order interpolation formulas can also be 
employed. 
  64Figure 1: Comparison of the tumor radius evolution in time for the spherically symmetric
geometry obtained using two solution methods: a pseudo-Lagrangian method and an Eule-
rian/level set method. The model parameters are given by (4.16) with initial tumor radius
R0 = 2 and outer environment radius RD = 10.
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66Figure 3: Evolution of the tumor living cell density at various moments in time for spherically
symmetric tumor growth (Figure 1 parameters). The ﬁrst four curves correspond to the
avascular phase of tumor growth, the ﬁfth one to an intermediate (vascularization) phase
and the last two to a fully vascular phase.
67Figure 4: Evolution of the tumor dead cell density at various moments in time for spherically
symmetric tumor growth (Figure 1 parameters). Formation of a necrotic core in the central
region of the tumor observed.
68 
 
 
 
 
 
 
 
Figure 5: Evolution of the new capillary density at various moments in time for spheri-
cally symmetric tumor growth (Figure 1 parameters). The endothelial cells stimulated to
proliferate belong to the pre-existing capillary network, here located on the line segment
7 ≤ r ≤ 8..
69Figure 6: Evolution of the overall cell density inside the tumor at three moments in time
for spherically symmetric tumor growth (Figure 1 parameters). Development of increasingly
sharp local gradients occurs.
70 
 
 
 
 
 
 
 
Figure 7: Evolution of the tumor angiogenic factor (TAF) at various moments in time, in
the avascular and in the vascular phase of growth, for spherically symmetric tumor growth
(Figure 1 parameters).
71(a) avascular phase
(b) vascular phase
Figure 8: Nutrient evolution inside the tumor in the (a) avascular phase and in the (b)
vascular phase of growth for spherically symmetric tumor growth (Figure 1 parameters).
Nutrient levels are maximum at the tumor surface and gradually decreasing towards the
center. 72Figure 9: Comparison of the tumor radius evolution in time computed via three diﬀerent
methods: 2D Cartesian/narrow band level set method, 1D pseudo-Lagrangian method under
the assumption of polar symmetry and a 1D Eulerian/level set method under the assumption
of polar symmetry. The initial tumor boundary is a circle of center 0 and radius 1. The
model parameters are given by (4.16), except that ˆ UC = 0.5 in the pre-existing capillary
region.
73Figure 10: Mesh reﬁnement analysis for the 2D simulations. The tumor initial boundary is
deﬁned by Eq. (6.1). Quantitative results are presented in Table 1.
74Figure 11(a): Evolution of the tumor in time, for the initial tumor boundary given by
Eq.(6.1). The four small circles outside of the initial tumor boundary correspond to the
location of the pre-existing capillaries. The model parameters are the same as Figure 9.
75Figure 11(b-1): Evolution of the new capillary density displayed as contour plots for the
conditions of Figure 11(a).
76Figure 11(b-2): Evolution of the new capillary density displayed as surface plots for the
conditions of Figure 11(a).
77Figure 11(c): Evolution of tumor living cell density displayed as contour plots for the con-
ditions of Figure 11(a).
78Figure 11(d): Evolution of tumor dead cell density displayed as contour plots for the condi-
tions of Figure 11(a). The tendency to form a large necrotic region is observed.
79Figure 11(e): Evolution of tumor angiogenic factor (TAF) displayed as contour plots for the
conditions of Figure 11(a).
80Figure 11(f): Evolution of nutrient concentration displayed as contour plots for the conditions
of Figure 11(a).
81Figure 12(a): Evolution of the tumor in time, for the initial tumor boundary given by
Eq.(6.4). The initial size of the tumor and the overall domain have been scaled down by a
factor of four. The four small circles outside of the initial tumor boundary correspond to
the location of the pre-existing capillaries. The model parameters are given by (4.16).
82Figure 12(b-1): Evolution of the new capillary density displayed as contour plots for the
conditions of Figure 12(a).
83Figure 12(b-2): Evolution of the new capillary density displayed as surface plots for the
conditions of Figure 12(a).
84Figure 12(c): Evolution of tumor living cell density displayed as contour plots for the con-
ditions of Figure 12(a).
85Figure 12(d): Evolution of tumor dead cell density displayed as contour plots for the condi-
tions of Figure 12(a). The tendency to form a large necrotic region is observed.
86Figure 12(e): Evolution of tumor angiogenic factor (TAF) displayed as contour plots for the
conditions of Figure 12(a).
87Figure 12(f): Evolution of nutrient concentration displayed as contour plots for the conditions
of Figure 12(a).
88Figure 13: Evolution of an asymmetric, multimodal tumor boundary deﬁned by Eq.(6.5)
initially. The location of the existing capillaries is marked by the small dashed gray circle
(centered at (1.5,1.5) with radius 0.3). Equal time increments of 0.25 are shown, from t = 0
to t = 2.5. Model parameters as in Figure 11, except that ˆ UC = 0.5 in the pre-existing
capillary region, ¯ UC = 0.4 and KS = 10.
89Figure 14: A comparison of the tumor boundary evolution for two model parameters char-
acterizing the vascular phase of growth: KS and ΓC. The initial tumor boundary (same as
Figure 13) is shown as the gray solid line. The tumor boundary at the ﬁnal time t = 2.5 is
shown as follows: KS = 10 and ΓC = 10, dotted line; KS = 0 and ΓC = 100, dash-dot line;
KS = 10 and ΓC = 100, solid line.
90